Mr Mrs Miss Ms Dr Other

Dr
Christopher
Mellor

Patent Director

Edinburgh Office

Chemistry

Telephone. +44(0) 131 220 7500
Mobile. +44(0) 758 447 7868
Email. cmellor@hgf.com
UPC Representative
Our team of specialist European patent litigators, oppositions specialists and patent attorneys bring together an extensive depth of legal and technical knowledge and are qualified to represent you in the UPC.
Vcard
Linkedin

Experience

Chris has more than eight years’ experience in the patent profession, specialising in the field of chemistry, particularly medical devices, polymers, biochemistry, pharmaceuticals and surface chemistry. As well as drafting and prosecuting patent applications, he handles contentious EPO opposition and appeal proceedings, provides strategic advice on IP portfolios, and opinions on the infringement and validity of patents.

Specialisms

Industries

Services

Qualifications

Patent Attorney

Chartered (UK)
Europe

MCHEM

University of Oxford

PHD

University of Oxford

Recognition

MIP IP Rising Stars 2019/20

The guide highlights the best-performing non-partners who have contributed to the success of their firms and clients in recent years. Results are based on the information, including client feedback and peer responses obtained during the research for the 2019/20 edition of IP Stars.

View recognition online

Download recognition PDF

Publications

12 HGF Attorneys Recognised as Managing IP Rising Stars 2025

View publication online

Managing Intellectual Property practitioner rankings – IP Stars 2025

View publication online

Managing IP Rising Stars 2024

View publication online

Managing IP's Rising Stars 2021

View publication online

MIP IP Rising Stars 2020/2021

View publication online

MIP IP Rising Stars 2019/20

View publication online

Related News

Office Closed Dates December 2025 / January 2026

HGF Office Closed Dates December 2025 / January 2026   UK Thursday 25 and Friday 26 December 2025 CLOSED Thursday 1 January 2026* CLOSED * Friday 2 January 2026 – …

Read article

PRESS RELEASE – HGF strengthens European presence with three new Partners in France and Germany

HGF is pleased to announce the arrival of three new partners, further strengthening its European presence. Two partners will be joining the firm’s fast-growing French practice, and one will join …

Read article

The EPO Board of Appeal comments on the scope of the morality exclusion from patentability

The recent decision, T1553/22 of the Board of Appeal required the Board to consider the scope of the exclusions from patentability under Article 53(a) EPC. The invention in this case …

Read article

Agritech Thymes: Unlocking the Soil Microbiome: Driving Agritech Innovation in the UK

The UK offers an ideal platform for harnessing the untapped potential of soil and plant microorganisms. Although much of my professional experience has focused on the human microbiome, I have …

Read article

The Antibody Series #1 | Quality Characteristics (CQAs) in Antibody Claims: When the Test Method Can Remain Outside the Claim

Introduction Therapeutic antibodies are at the heart of innovations in biotechnology and healthcare. With increasing regulatory requirements and quality expectations, critical quality attributes (CQAs) are becoming essential in the drafting …

Read article
Event - 3rd February 2026

HGF Brand & Design Conference 2026

Join us on 3rd February 2026 for HGF’s Brand & Design Conference, the must attend event for in-house legal teams, brand leaders, creatives, and innovators shaping the future of IP. …

Event details

EU Agrees on NGT Plant Regulation: What It Means for Patents and Licensing

The European Parliament and Council have reached a provisional agreement for plants developed using New Genomic Techniques (NGTs) – below we summarise the main points and set out the requirements …

Read article
See all updates

Let's talk

If you would like to discuss how HGF could help you, contact one of our IP specialists.

Contact us